Short Information | Sinovac Biotech Ltd. (NASDAQ:SVA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 11,480 |
Total Actual Volume | 165,945 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 574 |
Average Short Percentage | 7.44% |
Is there a SVA Short Squeeze or Breakout about to happen?
See the SVA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-22-2019 | $6.49 | $6.47 | $6.58 | $6.2501 | 8,227 | 1,329 | 16.15% |
02-21-2019 | $6.50 | $6.49 | $6.51 | $6.47 | 7,744 | 91 | 1.18% |
02-20-2019 | $6.48 | $6.43 | $6.51 | $6.43 | 8,415 | 664 | 7.89% |
02-19-2019 | $6.45 | $6.47 | $6.5099 | $6.45 | 5,618 | 557 | 9.91% |
02-15-2019 | $6.65 | $6.43 | $6.65 | $6.31 | 48,812 | 1,586 | 3.25% |
02-14-2019 | $6.54 | $6.65 | $6.65 | $6.53 | 2,836 | 36 | 1.27% |
02-13-2019 | $6.49 | $6.48 | $6.6499 | $6.48 | 5,066 | 381 | 7.52% |
02-12-2019 | $6.48 | $6.48 | $6.69 | $6.42 | 17,307 | 1,770 | 10.23% |
02-11-2019 | $6.53 | $6.53 | $6.59 | $6.52 | 1,147 | 62 | 5.41% |
02-08-2019 | $6.49 | $6.62 | $6.62 | $6.49 | 2,804 | 75 | 2.67% |
02-07-2019 | $6.568 | $6.52 | $6.61 | $6.4813 | 4,776 | 286 | 5.99% |
02-06-2019 | $6.4823 | $6.61 | $6.69 | $6.4823 | 9,038 | 1,331 | 14.73% |
02-05-2019 | $6.57 | $6.56 | $6.66 | $6.5501 | 4,036 | 323 | 8% |
02-04-2019 | $6.55 | $6.63 | $6.64 | $6.50 | 3,611 | 219 | 6.06% |
02-01-2019 | $6.62 | $6.59 | $6.62 | $6.50 | 13,462 | 767 | 5.7% |
01-31-2019 | $6.56 | $6.39 | $6.57 | $6.38 | 5,583 | 494 | 8.85% |
01-30-2019 | $6.51 | $6.45 | $6.5899 | $6.45 | 4,305 | 340 | 7.9% |
01-29-2019 | $6.339 | $6.33 | $6.37 | $6.32 | 4,236 | 454 | 10.72% |
01-28-2019 | $6.509 | $6.45 | $6.509 | $6.45 | 2,410 | 167 | 6.93% |
01-25-2019 | $6.50 | $6.40 | $6.51 | $6.32 | 6,512 | 548 | 8.42% |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...